Drug class in one race
PD-L1 drugs for HR+/HER2- Metastatic Breast Cancer
2 tracked PD-L1 drugs in the HR+/HER2- Metastatic Breast Cancer race. The class explanation lives on the PD-L1 page; the full indication pipeline across every mechanism is on the HR+/HER2- Metastatic Breast Cancer page.
2 Phase 2